[A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis].
D000328:Adult; D001578:Benzopyrans / Q000627:therapeutic use*; D002392:Catechin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos
D001578:Benzopyrans; D010919:Placebos; D002392:Catechin
Ricerca clinica in doppia cecità di una nuova molecola (+)-cyanidanol-3 sull'evoluzione dei sintomi clinici e dei parametri biologici dell'epatite virale.U